PFIZER INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
- Conditions
- MycosesMycobacterium Avium-Intracellulare InfectionHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 720
- Registration Number
- NCT00002122
- Locations
- ๐บ๐ธ
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
๐บ๐ธUCSD Treatment Ctr / Dept of Medicine and Pediatrics, San Diego, California, United States
๐บ๐ธUniv of Massachusetts Med Ctr, Worcester, Massachusetts, United States
Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
- Conditions
- Meningitis, CryptococcalHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002076
- Locations
- ๐บ๐ธ
Summitt Med Ctr / San Francisco Gen Hosp, Oakland, California, United States
๐บ๐ธCornell Univ Med Ctr, New York, New York, United States
๐บ๐ธBuckley Braffman Stern Med Associates, Philadelphia, Pennsylvania, United States
A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
- Conditions
- Meningitis, CryptococcalHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002068
- Locations
- ๐บ๐ธ
Christiana Hosp / Med Ctr of Delaware, Wilmington, Delaware, United States
๐บ๐ธUniv of Tennessee, Memphis, Tennessee, United States
๐บ๐ธDavies Med Ctr, San Francisco, California, United States
An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy
- Conditions
- HIV InfectionsMycobacterium Avium-Intracellulare Infection
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002089
- Locations
- ๐บ๐ธ
Pfizer Central Research, Groton, Connecticut, United States
Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
- Conditions
- Meningitis, CryptococcalHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002040
- Locations
- ๐บ๐ธ
Cook County Hosp, Chicago, Illinois, United States
๐บ๐ธSummitt Med Ctr / San Francisco Gen Hosp, Oakland, California, United States
๐บ๐ธCornell Univ Med Ctr, New York, New York, United States
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
- Conditions
- MycosesCoccidioidomycosisHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002325
- Locations
- ๐บ๐ธ
Tucson Veterans Administration Med Ctr, Tucson, Arizona, United States
๐บ๐ธMcDowell Clinic, Phoenix, Arizona, United States
๐บ๐ธDr Lawrence Cone, Rancho Mirage, California, United States